Call for Science

ASE invites all investigators to submit abstracts of basic or clinical research to be considered for poster presentation at the 28th Annual Echo Hawaii meeting.

Key Dates

September 1, 2017 Submission opens
November 1, 2017 Deadline for abstract submission (11:59 PM Eastern Time)
November 20, 2017 Notification to Presenting Authors
January 15-19, 2018 28th Annual Echo Hawaii
January 17, 2018 Poster Session & Reception

Why Submit Your Science to Echo Hawaii?

Abstract presenters at the 28th Annual Echo Hawaii receive:

  • Support – Presenting authors are eligible for a $100 discount off their conference registration fee.
  • Awareness, Visibility, and Feedback – Experts in cardiovascular research will see your science, and the dedicated viewing time provides an opportunity to discuss your work with faculty and attendees. A “Best Poster Prize” will also be awarded to recognize the top poster presented.

Abstracts that have previously been presented at another meeting are welcome. Presenters should also note that the abstracts accepted for this meeting are not published. As such, presentation of your work at Echo Hawaii may not interfere with its future presentation at another national meeting.

Presentation Format – Moderated Poster

Submitted abstracts are peer-reviewed by a panel of graders. Selection for presentation is based solely on scientific merit.

Accepted abstracts will be presented as a poster on the evening of Wednesday, January 17, 2018. Presenting authors are required to attend their poster during this dedicated poster reception and viewing time. Members of the faculty will moderated your work, allowing you an opportunity to briefly present your key findings for commentary from our internationally-renowned faculty. A “Best Poster Prize” will be awarded based on the moderators’ selection.

ASE will provide poster boards that measure four feet high (121 cm) and three feet wide (92 cm). Note that this poster board is smaller than those typically used at scientific meetings and is in “portrait” orientation.

Submit Your Science to ASE Today

Please review the submission and presentation guidelines below, and then email your abstract to avanhoever@asecho.org. Material should be sent in a Word or PDF file, and must include the abstract Title; Authors and Affiliations; your study summarized into Background, Methods, Results and Conclusion sections; as well as Author Disclosures, if any.

 

SUBMISSION & PRESENTATION GUIDELINES

General Information

  • Authors do not need to be ASE members to participate.
  • Abstract submission is free of charge. However, any expenses (e.g., registration, airfare, lodging, etc.) associated with the submission and presentation of an abstract are the sole responsibility of the presenter.
  • Echo Hawaii only accepts abstracts of basic or clinical research. Case reports are not considered for presentation.
  • Presenting authors are eligible for a $100 discount off their conference registration fee. This discount is restricted to the presenting author only; co-authors are not eligible.
  • Submission of an abstract constitutes a commitment by the author(s) to present if accepted. Presenting authors are expected to register for the Echo Hawaii meeting within two weeks of acceptance notification, or risk forfeiting their presentation assignment.

Submission Details and Deadlines

  • Abstract submission opens Friday, September 1, 2017.
  • Abstracts must be submitted in their final form by 11:59 PM Eastern Time on Wednesday, November 1, 2017.
  • Authors must follow all instructions for completing their submission.
  • ASE is not responsible for work that is not submitted by the submission deadline. No new abstracts will be accepted after the submission deadline.

Author Names(s) and Affiliation(s)

  • Abstracts must include the first and last names for all authors. Do not list authors by initial only.
  • All authors are required to comply with ASE’s Disclosure Policy, and are expected to disclose any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing medical education activity. This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, and/or other corporations whose products or services are related to the subject matter of the research topic.
  • If an abstract is accepted for presentation, the presenter must be one of the authors listed on the submission.

Content and Format

  • Character limit – Abstracts are limited to 500 words. This includes the text, but not the title or authors.
  • Tables/Graphics – The use of up to two (2) tables and/or graphics is encouraged if they are relevant to the research submitted. These images can either be embedded within your abstract file or submitted as separate attachments.
  • Abbreviations – A maximum of five (5) unique abbreviations is allowed within the body of the abstract.
  • Format – Content should be structured into the following four (4) sections:
    • Background:
    • Methods:
    • Results:
    • Conclusion:
  • Clarity of expression will be considered in the review process. The overall quality of language used should assure comprehension by the reader.
  • Do not include
    • References or credits.
    • Names or personal information of any patient participating in the study or trial. If you do, the abstract will not be considered for presentation.
    • Authors or institutions in the title.
  • Proofread abstracts carefully to avoid errors.

Eligibility

  • Any human experimentation must conform to the principles of the Declaration of Helsinki of the World Medical Association.
  • ASE endorses the position of the American Association for the Advancement of Science (AAAS) in requiring assurances of the responsible use of animals in research. All submissions for consideration must be in compliance with these guidelines (AAAS Resolution: Use of Animals in Research, Testing, and Education).

Presentation

  • All accepted abstracts will be presented as a moderated poster.
  • All presentations and question-and-answer periods will be in English. If presenters need assistance in understanding or responding to questions in English, they are encouraged to have a member of their research team assist them.
  • All presenting authors are required to comply with ASE’s Disclosure Policy, and are expected to disclose to the audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing medical education activity. This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic.

Disclosure

  • All abstracts submitted to Echo Hawaii are disclosed to members of the peer-review selection committee, as well as to ASE employees and contractors as necessary in connection with the 28th Annual Echo Hawaii program. Notwithstanding these policies and procedures, ASE is not subject to any confidentiality requirements with respect to submitted abstracts. In addition, compliance with any disclosure or nondisclosure requirements that apply to researchers or research sponsors (whether under federal securities laws, contract agreement, or otherwise) is the sole responsibility of the researcher and/or sponsor, and not ASE.

Abstract Withdrawal

Questions or Need Assistance with Your Submission?

CMS finalized increase to echo code 93306 and accepted the cardiology community’s proposal that prevents cuts to echoes with contrast